2019
DOI: 10.1002/slct.201903418
|View full text |Cite
|
Sign up to set email alerts
|

Hybrids of Isatin‐Pyrazole as Potential α‐Glucosidase Inhibitors: Synthesis, Biological Evaluations and Molecular Docking Studies

Abstract: α‐Glucosidase inhibition has been considered as an effective strategy for controlling the post‐prandial hyperglycemia in diabetic patients. A series of novel isatin‐pyrazole hybrids has been rationally designed, synthesized and characterized by different spectroscopic techniques. All of the synthesized compounds were evaluated for their α‐glucosidase inhibitory potential using in vitro enzymatic assay. The tested compounds have exhibited potent α‐glucosidase inhibition with IC50 values ranging from 3.26±0.25 t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…Appropriately in silico pharmacokinetic properties for hybrids with enhanced α-glucosidase inhibitory activity could catalyze future production and development of physiologically active α-glucosidase inhibitors. [70] A series of novel antidiabetic drugs containing via pyrazolylthiazolidin-4-one pharmacophore has been designed and containing methoxy groups on the phenyl ring and nitro groups on the pyrazole ring that were coupled to thiazolidine-4-one had the highest total (e.s.u) value. High second-order nonlinear optical characteristics are related with substances replaced with electronwithdrawing groups on one side and electron-releasing groups on another side.…”
Section: Pyrazole Derivatives As α-Glucosidase Inhibitorsmentioning
confidence: 99%
“…Appropriately in silico pharmacokinetic properties for hybrids with enhanced α-glucosidase inhibitory activity could catalyze future production and development of physiologically active α-glucosidase inhibitors. [70] A series of novel antidiabetic drugs containing via pyrazolylthiazolidin-4-one pharmacophore has been designed and containing methoxy groups on the phenyl ring and nitro groups on the pyrazole ring that were coupled to thiazolidine-4-one had the highest total (e.s.u) value. High second-order nonlinear optical characteristics are related with substances replaced with electronwithdrawing groups on one side and electron-releasing groups on another side.…”
Section: Pyrazole Derivatives As α-Glucosidase Inhibitorsmentioning
confidence: 99%
“…Similarly, Kaur et al [36] synthesized 4-formyl-1-phenylpyrazoles 31a-f using the Vilsmeier-Haack reaction with phenylhydrazones 30a-f, POCl 3 , and DMF. The corresponding substrates 30a-f were obtained by a condensation reaction between phenylhydrazine (9a) and acetophenones 24a-f in ethanol using acetic acid as a catalyst (Scheme 7a).…”
Section: Formylpyrazolesmentioning
confidence: 99%
“…However, acarbose and voglibose are expensive and have some side effects such as flatulence or abdominal bloating [2,3] . Therefore, the development of new α‐glucosidase inhibitors from both natural and synthetic sources is always necessary [4–11] . Like crown ether, thiacrown ether can be used selectively for metal ions in solution.…”
Section: Introductionmentioning
confidence: 99%
“…[2,3] Therefore, the development of new α-glucosidase inhibitors from both natural and synthetic sources is always necessary. [4][5][6][7][8][9][10][11] Like crown ether, thiacrown ether can be used selectively for metal ions in solution. However, in comparison with crown ethers, studies about thiacrown ether derivatives are still limited.…”
Section: Introductionmentioning
confidence: 99%